{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T04:44:37Z","timestamp":1727412277471},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,26]]},"DOI":"10.7759\/cureus.70285","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T01:46:47Z","timestamp":1727401607000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Serum Uric Acid With Cardiovascular Risk in Nigerian Patients"],"prefix":"10.7759","author":[{"given":"Ugochi C","family":"Okorafor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiamaka I","family":"Okorafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casmir","family":"Amadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okam","family":"Onyinye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nnanna","family":"Achime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.08.110","article-title":"Relation of serum uric acid to cardiovascular disease","volume":"213","author":"Wu AH","year":"2016","unstructured":"Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G. Relation of serum uric acid to cardiovascular disease. Int J Cardiol. 2016, 213:4-7. 10.1016\/j.ijcard.2015.08.110","journal-title":"Int J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5336\/intermed.2017-59452","article-title":"Why serum uric acid is important for the development of atherogenic vascular disease?","volume":"3","author":"Bardak S","year":"2018","unstructured":"Bardak S, Uluk\u00f6ksal U, Mavi MK, et al.. Why serum uric acid is important for the development of atherogenic vascular disease?. Turkiye Klinikleri J Intern Med. 2018, 3:61-6. 10.5336\/intermed.2017-59452","journal-title":"Turkiye Klinikleri J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.36.6.1072","article-title":"Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study","volume":"36","author":"Verdecchia P","year":"2000","unstructured":"Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension. 2000, 36:1072-8. 10.1161\/01.hyp.36.6.1072","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02263.x","article-title":"The association between serum uric acid level and coronary artery disease","volume":"64","author":"Sinan Deveci O","year":"2010","unstructured":"Sinan Deveci O, Kabakci G, Okutucu S, et al.. The association between serum uric acid level and coronary artery disease. Int J Clin Pract. 2010, 64:900-7. 10.1111\/j.1742-1241.2009.02263.x","journal-title":"Int J Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.24164","article-title":"Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study","volume":"61","author":"Chen JH","year":"2009","unstructured":"Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum. 2009, 61:225-32. 10.1002\/art.24164","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.23121","article-title":"Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study","volume":"58","author":"Ioachimescu AG","year":"2008","unstructured":"Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum. 2008, 58:623-30. 10.1002\/art.23121","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12149","article-title":"Uric acid measurement improves prediction of cardiovascular mortality in later life","volume":"61","author":"Dutta A","year":"2013","unstructured":"Dutta A, Henley W, Pilling LC, Wallace RB, Melzer D. Uric acid measurement improves prediction of cardiovascular mortality in later life. J Am Geriatr Soc. 2013, 61:319-26. 10.1111\/jgs.12149","journal-title":"J Am Geriatr Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S61363","article-title":"Serum uric acid and target organ damage in essential hypertension","volume":"10","author":"Ofori SN","year":"2014","unstructured":"Ofori SN, Odia OJ. Serum uric acid and target organ damage in essential hypertension. Vasc Health Risk Manag. 2014, 10:253-61. 10.2147\/VHRM.S61363","journal-title":"Vasc Health Risk Manag"},{"key":"ref9","article-title":"Serum uric acid levels and its association with cardiovascular risk factors","volume":"38","author":"Sadr SM","year":"2009","unstructured":"Sadr SM, Namayandeh SM, Moadares MM, Rafiei M. Serum uric acid levels and its association with cardiovascular risk factors. Iranian J Publ Health. 2009, 38:53-9.","journal-title":"Iranian J Publ Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","unstructured":"Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285.2486-97. 10.1001\/jama.285.19.2486","journal-title":"JAMA"},{"key":"ref11","article-title":"Physical status: the use of and interpretation of anthropometry, report of a WHO expert committee","year":"1995","unstructured":"Physical status. the use of and interpretation of anthropometry, report of a WHO expert committee. WHO Technical Report Series. World Health Organization, Geneva; 1995. 321-44."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(05)67402-8","article-title":"The metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti KG","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005, 366:1059-62. 10.1016\/s0140-6736(05)67402-8","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino RB Sr","year":"2008","unstructured":"D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008, 117:743-53. 10.1161\/CIRCULATIONAHA.107.699579","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v23i1.54","article-title":"Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda","volume":"23","author":"Lumu W","year":"2023","unstructured":"Lumu W, Bahendeka S, Wesonga R, Kibirige D, Kasoma RM, Ssendikwanawa E. Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda. Afr Health Sci. 2023, 23:515-27. 10.4314\/ahs.v23i1.54","journal-title":"Afr Health Sci"},{"key":"ref15","article-title":"Evaluation of cardiovascular, anthropometric and electrolyte correlates of serum uric acid in young adult Nigerians","volume":"8","author":"Emem-Chioma PC","year":"2020","unstructured":"Emem-Chioma PC, Oko-Jaja RI, Alasia DD. Evaluation of cardiovascular, anthropometric and electrolyte correlates of serum uric acid in young adult Nigerians. Am J Biomed Res. 2020, 8:25-9.","journal-title":"Am J Biomed Res"},{"key":"ref16","article-title":"Prevalence of hyperuricaemia in a rural population of Nigerian Niger Delta Region","volume":"22","author":"Alikor CA","year":"2013","unstructured":"Alikor CA, Emem-Chioma PC. Prevalence of hyperuricaemia in a rural population of Nigerian Niger Delta Region. Niger J Med. 2013, 22:187-92.","journal-title":"Niger J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-2-24","article-title":"Hyperuricaemia and the metabolic syndrome in type 2 DM","volume":"2","author":"Ogbera AO","year":"2010","unstructured":"Ogbera AO, Azenabor AO. Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr. 2010, 2:24. 10.1186\/1758-5996-2-24","journal-title":"Diabetol Metab Syndr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5455\/jmp.20150915011842","article-title":"Prevalence of hyperuricemia and its risk factors in healthy male adults from Abakaliki metropolis, Nigeria","volume":"4","author":"Ewenighi Chinwe O","year":"2015","unstructured":"Ewenighi Chinwe O, Uchechukwu D, Uchechukwu E, Joel O, Linus O, Babatunde A, Gladys O. Prevalence of hyperuricemia and its risk factors in healthy male adults from Abakaliki metropolis, Nigeria. J Mol Pathophysiol. 2015, 4:94-8. 10.5455\/jmp.20150915011842","journal-title":"J Mol Pathophysiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.9734\/bjmmr\/2015\/16448","article-title":"Hyperuricaemia and its relations with serum lipid abnormalities in untreated, newly diagnosed adult Nigerian hypertensive patients","volume":"7","author":"Fasae A","year":"2015","unstructured":"Fasae A, Busari O, Opadijo O, Omotoso A. Hyperuricaemia and its relations with serum lipid abnormalities in untreated, newly diagnosed adult Nigerian hypertensive patients. Br J Med Med Res. 2015, 7:779-88. 10.9734\/bjmmr\/2015\/16448","journal-title":"Br J Med Med Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16234632","article-title":"Association of serum uric acid with cardiovascular disease risk scores in Koreans","volume":"16","author":"Lee SY","year":"2019","unstructured":"Lee SY, Park W, Suh YJ, et al.. Association of serum uric acid with cardiovascular disease risk scores in Koreans. Int J Environ Res Public Health. 2019, 16:4632. 10.3390\/ijerph16234632","journal-title":"Int J Environ Res Public Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22997-0","article-title":"Association between serum uric acid and cardiovascular risk in nonhypertensive and nondiabetic individuals: The Taiwan I-Lan Longitudinal Aging Study","volume":"8","author":"Chang CC","year":"2018","unstructured":"Chang CC, Wu CH, Liu LK, et al.. Association between serum uric acid and cardiovascular risk in nonhypertensive and nondiabetic individuals: The Taiwan I-Lan Longitudinal Aging Study. Sci Rep. 2018, 8:5234. 10.1038\/s41598-018-22997-0","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e3282f394a5","article-title":"Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score","volume":"9","author":"Halil M","year":"2008","unstructured":"Halil M, Yavuz B, Yavuz BB, et al.. Novel cardiovascular risk factors in the elderly and their correlation with the Framingham risk score. J Cardiovasc Med (Hagerstown). 2008, 9:683-7. 10.2459\/JCM.0b013e3282f394a5","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3109\/13813455.2012.732580","article-title":"Serum uric acid: marker for atherosclerosis as it is positively associated with \"atherogenic index of plasma\"","volume":"119","author":"Baliarsingh S","year":"2013","unstructured":"Baliarsingh S, Sharma N, Mukherjee R. Serum uric acid: marker for atherosclerosis as it is positively associated with \"atherogenic index of plasma\". Arch Physiol Biochem. 2013, 119:27-31. 10.3109\/13813455.2012.732580","journal-title":"Arch Physiol Biochem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0222-7","article-title":"Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women","volume":"15","author":"Nansseu JR","year":"2016","unstructured":"Nansseu JR, Moor VJ, Nouaga ME, Zing-Awona B, Tchanana G, Ketcha A. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women. Lipids Health Dis. 2016, 15:49. 10.1186\/s12944-016-0222-7","journal-title":"Lipids Health Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2020.12.013","article-title":"Uric acid and cardiovascular disease: a clinical review","volume":"78","author":"Saito Y","year":"2021","unstructured":"Saito Y, Tanaka A, Node K, Kobayashi Y. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021, 78:51-7. 10.1016\/j.jjcc.2020.12.013","journal-title":"J Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01568","article-title":"Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide","volume":"10","author":"Sun HJ","year":"2019","unstructured":"Sun HJ, Wu ZY, Nie XW, Bian JS. Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide. Front Pharmacol. 2019, 10:1568. 10.3389\/fphar.2019.01568","journal-title":"Front Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.582680","article-title":"Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective","volume":"11","author":"Yu W","year":"2020","unstructured":"Yu W, Cheng JD. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol. 2020, 11:582680. 10.3389\/fphar.2020.582680","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/285922-correlation-of-serum-uric-acid-with-cardiovascular-risk-in-nigerian-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T01:46:50Z","timestamp":1727401610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/285922-correlation-of-serum-uric-acid-with-cardiovascular-risk-in-nigerian-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.70285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}